[USA] It has taken eight years for Boston Children’s Hospital and Chilean company Proteus to figure out how to create an improved class of anesthetics.
And now, thanks to an $85 million Continue reading Boston Children's makes deal to bring new red algae-derived anesthetic to market
New Orleans—The duration of sensory blockade was significantly prolonged by a novel site 1 sodium channel blocker that belongs to the class of paralytic shellfish toxins.
This first-in-human trial was reported at Continue reading Novel Compound from Algae Yields Long-Acting Anesthetic Effect
Your one-stop algae industry information platform